IL118021A0 - Modified polypeptides for enhanced immunogenicity - Google Patents

Modified polypeptides for enhanced immunogenicity

Info

Publication number
IL118021A0
IL118021A0 IL11802196A IL11802196A IL118021A0 IL 118021 A0 IL118021 A0 IL 118021A0 IL 11802196 A IL11802196 A IL 11802196A IL 11802196 A IL11802196 A IL 11802196A IL 118021 A0 IL118021 A0 IL 118021A0
Authority
IL
Israel
Prior art keywords
modified polypeptides
enhanced immunogenicity
immunogenicity
enhanced
polypeptides
Prior art date
Application number
IL11802196A
Other languages
English (en)
Original Assignee
Rmf Dictagene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rmf Dictagene Sa filed Critical Rmf Dictagene Sa
Publication of IL118021A0 publication Critical patent/IL118021A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL11802196A 1995-04-25 1996-04-23 Modified polypeptides for enhanced immunogenicity IL118021A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/428,616 US6113917A (en) 1995-04-25 1995-04-25 Modified polypeptides for enhanced immunogenicity
EP95201066 1995-04-25
NL1001348A NL1001348C2 (en) 1995-04-25 1995-10-05 Polypeptide comprising glycosyl-phosphatidyl:inositol structure

Publications (1)

Publication Number Publication Date
IL118021A0 true IL118021A0 (en) 1996-08-04

Family

ID=26139248

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11802196A IL118021A0 (en) 1995-04-25 1996-04-23 Modified polypeptides for enhanced immunogenicity

Country Status (15)

Country Link
US (1) US6113917A (no)
EP (1) EP0826050A1 (no)
JP (1) JPH11504215A (no)
AU (1) AU714808B2 (no)
BR (1) BR9604989A (no)
CA (1) CA2218987A1 (no)
CZ (1) CZ291013B6 (no)
HU (1) HUP9802238A3 (no)
IL (1) IL118021A0 (no)
NL (1) NL1001348C2 (no)
NO (1) NO974924L (no)
NZ (1) NZ307195A (no)
PL (1) PL323078A1 (no)
WO (1) WO1996034105A1 (no)
ZA (1) ZA963269B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997026911A1 (en) 1996-01-29 1997-07-31 Georgetown University Malaria vaccine based upon the addition of a msa1 peptide
AUPP589398A0 (en) 1998-09-14 1998-10-08 Walter And Eliza Hall Institute Of Medical Research, The Immunogenic compositions and uses thereof
AUPP675898A0 (en) * 1998-10-27 1998-11-19 Walter And Eliza Hall Institute Of Medical Research, The A method of activating t cells and agents useful for same
IL161296A0 (en) * 2001-10-13 2004-09-27 Asterion Ltd Glycosylphosphatidylinositol containing polypeptides
US20030171260A1 (en) * 2002-03-11 2003-09-11 Nelson Deanna Jean Compositions and methods utilizing hydroxamates to scavenge oxidant toxins
CN1681529B (zh) 2002-07-26 2012-09-19 沃尔特及伊莱萨霍尔医学研究院 免疫组合物及其诊断和治疗用途
JP2007527695A (ja) * 2003-04-09 2007-10-04 アステリオン・リミテッド グリコシルホスファチジルイノシトールを含有するポリペプチド
US20080026008A1 (en) * 2006-07-27 2008-01-31 Clark Tibbs Bacteriophage DNA vaccine vector

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8905857D0 (en) * 1989-03-14 1989-04-26 Hoffmann La Roche Plasmodium merozoite rhoptries antigen
NL9100869A (nl) * 1991-05-17 1992-12-16 Univ Lausanne Dictyostelide expressievector en werkwijze voor het tot expressie brengen van een gewenst eiwit.
BR9400600A (pt) * 1994-02-17 1995-10-24 Finep Financiadora De Estudos Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processos

Also Published As

Publication number Publication date
BR9604989A (pt) 1999-11-30
EP0826050A1 (en) 1998-03-04
CZ291013B6 (cs) 2002-11-13
NO974924L (no) 1997-12-19
HUP9802238A2 (hu) 1999-01-28
AU714808B2 (en) 2000-01-13
PL323078A1 (en) 1998-03-02
NO974924D0 (no) 1997-10-24
CZ337897A3 (cs) 1998-04-15
NL1001348C2 (en) 1996-10-28
NZ307195A (en) 1999-07-29
HUP9802238A3 (en) 2000-03-28
WO1996034105A1 (en) 1996-10-31
AU5648196A (en) 1996-11-18
ZA963269B (en) 1996-10-25
CA2218987A1 (en) 1996-10-31
US6113917A (en) 2000-09-05
JPH11504215A (ja) 1999-04-20

Similar Documents

Publication Publication Date Title
EP0793502A4 (en) NEW POLYPEPTIDES DERIVED FROM HEDGEHOG
GB9513261D0 (en) Vaccines
PT1090128E (pt) Polipéptidos dependentes da vitamina k modificados
HUP9800299A3 (en) Gnrh-leukotoxin chimeras
GB9500601D0 (en) Modified peptides
PL318017A1 (en) Peptides
EP0746565A4 (en) PEPTIDES RELATED TO BOMBESIN
HUP9802238A3 (en) Modified polypeptides for enhanced immunogenicity
GB9425380D0 (en) Peptides
GB9519511D0 (en) Peptides
GB2308509B (en) Services-connections for trailer-vehicles
GB9425381D0 (en) Peptides
GB2308393B (en) Windshelter for sun-bathing
GB2298174B (en) Services-connections for trailer-vehicles
EP0873349A4 (en) TYPE III POLYPEPTIDE ACTIVATOR OF MONOCYTES AND ENDOTHELIAL CELLS
GB9514580D0 (en) Polypeptide
GB9514835D0 (en) Polypeptide
GB9511092D0 (en) Peptides
ZA956331B (en) Peptides
GB9421408D0 (en) Peptides
GB9517269D0 (en) Vaccines
GB9513107D0 (en) Vaccines
GB9514088D0 (en) Vaccines
GB9508326D0 (en) Vaccines
GB9513443D0 (en) Vaccines